Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by our core values, Stay True to Why, Collaborate to Accelerate, Lead with Clarity, Boldly Innovative, and Own the Outcome, we are committed to transforming the future of treatment for autoimmune disease. Join us at the forefront of cell therapy innovation and help redefine what’s possible.
Title: Executive Director, Medical Writing
Reports to: Chief Regulatory Officer
Location: Emeryville (Hybrid) OR Remote (West coast hours preferred) Position Summary
The Executive Director, Medical Writing serves as the functional lead for Medical Writing, providing strategic and operational leadership across the full product lifecycle. This role is responsible for evolving the vision, operating model, and capabilities of the Medical Writing function while ensuring the delivery of high-quality, scientifically rigorous, and submission-ready documentation that supports Kyverna's development, regulatory, and commercialization objectives.
As a key member of the Regulatory leadership team, the Executive Director partners closely with Regulatory Affairs, Clinical Development, Clinical Operations, Biometrics, Medical Affairs, Pharmacovigilance, Quality, and Program Leadership to translate portfolio priorities into effective medical writing strategies and execution plans. This individual influences functional and portfolio decisions through operational expertise, identifies and mitigates regulatory documentation risks, and builds organizational capabilities that enable successful global submissions and lifecycle management.